Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 03 2023
10 03 2023
Historique:
received:
03
11
2022
accepted:
07
03
2023
entrez:
10
3
2023
pubmed:
11
3
2023
medline:
15
3
2023
Statut:
epublish
Résumé
Insect bite hypersensitivity (IBH) is the most common allergic skin disease of horses. It is caused by insect bites of the Culicoides spp. which mediate a type I/IVb allergy with strong involvement of eosinophil cells. No specific treatment option is available so far. One concept could be the use of a therapeutic antibody targeting equine interleukin 5, the main activator and regulator of eosinophils. Therefore, antibodies were selected by phage display using the naïve human antibody gene libraries HAL9/10, tested in a cellular in vitro inhibition assay and subjected to an in vitro affinity maturation. In total, 28 antibodies were selected by phage display out of which eleven have been found to be inhibiting in the final format as chimeric immunoglobulin G with equine constant domains. The two most promising candidates were further improved by in vitro affinity maturation up to factor 2.5 regarding their binding activity and up to factor 2.0 regarding their inhibition effect. The final antibody named NOL226-2-D10 showed a strong inhibition of the interleukin 5 binding to its receptor (IC
Identifiants
pubmed: 36899044
doi: 10.1038/s41598-023-31173-y
pii: 10.1038/s41598-023-31173-y
pmc: PMC10000358
doi:
Substances chimiques
Allergens
0
Interleukin-5
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4029Informations de copyright
© 2023. The Author(s).
Références
Structure. 2011 Dec 7;19(12):1864-75
pubmed: 22153509
Respir Res. 2001;2(2):71-9
pubmed: 11686868
J Allergy Clin Immunol. 2018 Oct;142(4):1194-1205.e3
pubmed: 29627082
Biochem Eng J. 2018 Sep 15;137:365-374
pubmed: 30666176
Sci Rep. 2020 Dec 7;10(1):21393
pubmed: 33288836
MAbs. 2016;8(1):120-8
pubmed: 26514880
Sci Rep. 2020 Jan 17;10(1):571
pubmed: 31953428
Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):50-65
pubmed: 22088675
Allergy. 2019 Mar;74(3):572-582
pubmed: 30402930
Allergy. 2020 Apr;75(4):862-871
pubmed: 31816097
Vet J. 2022 Oct;288:105896
pubmed: 36126798
J Cell Physiol. 2019 Jun;234(6):9486-9494
pubmed: 30417355
Nat Rev Immunol. 2006 Oct;6(10):761-71
pubmed: 16998509
J Cell Physiol. 2020 Sep;235(9):5867-5881
pubmed: 32057111
Equine Vet J. 1983 Jul;15(3):266-72
pubmed: 6884318
J Biotechnol. 2011 Apr 10;152(4):159-70
pubmed: 20883731
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4261-6
pubmed: 23440204
Vet Immunol Immunopathol. 2012 Jun 30;147(3-4):113-26
pubmed: 22575371
Antib Ther. 2021 Feb 18;4(1):45-54
pubmed: 33928235
Annu Rev Entomol. 2000;45:307-40
pubmed: 10761580
Vet Clin North Am Equine Pract. 2017 Apr;33(1):17-27
pubmed: 28325178
Methods Mol Biol. 2018;1701:393-407
pubmed: 29116518
Vet J. 2021 Oct;276:105741
pubmed: 34416400
BMC Biotechnol. 2015 Feb 19;15:10
pubmed: 25888378
Cell Rep. 2021 Jul 27;36(4):109433
pubmed: 34273271
Nat Biotechnol. 2004 Nov;22(11):1393-8
pubmed: 15529164
Sci Rep. 2017 Mar 28;7:45259
pubmed: 28349921
Methods Mol Biol. 2020;2070:143-155
pubmed: 31625094
Vet Rec. 2002 Dec 7;151(23):691-3
pubmed: 12503787
Nat Commun. 2021 Mar 11;12(1):1577
pubmed: 33707427
Acta Vet Scand. 2018 Nov 3;60(1):69
pubmed: 30390694
Methods Mol Biol. 2018;1701:273-284
pubmed: 29116510
Handb Exp Pharmacol. 2008;(181):47-68
pubmed: 18071941
J Am Chem Soc. 2013 Jul 10;135(27):9980-3
pubmed: 23795814
J Am Chem Soc. 2018 Feb 7;140(5):1976
pubmed: 29376652
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7855
pubmed: 28874538
Curr Opin Immunol. 2008 Jun;20(3):288-94
pubmed: 18511250
Vet Anaesth Analg. 2021 Nov;48(6):943-955
pubmed: 34565678
PLoS One. 2008;3(11):e3647
pubmed: 18985154
Microb Cell Fact. 2017 Jul 27;16(1):131
pubmed: 28750668
Methods Mol Biol. 2002;178:269-85
pubmed: 11968497
Mol Immunol. 2008 Feb;45(3):818-27
pubmed: 17669496
Front Vet Sci. 2021 May 28;8:610028
pubmed: 34124212
J Mol Biol. 1996 Jul 19;260(3):359-68
pubmed: 8757799
Cytokine. 2017 Oct;98:59-70
pubmed: 28863833
PLoS One. 2011 Jan 14;6(1):e15921
pubmed: 21264246
Vet J. 2011 Mar;187(3):347-51
pubmed: 20097587
Sci Rep. 2020 Mar 16;10(1):4807
pubmed: 32179767
Front Med (Lausanne). 2018 Apr 06;5:49
pubmed: 29682504
Expert Opin Biol Ther. 2020 Oct;20(10):1237-1244
pubmed: 32529893
Molecules. 2011 Jan 10;16(1):412-26
pubmed: 21221060
J Immunol Methods. 2005 Apr;299(1-2):47-62
pubmed: 15914190
Mol Biotechnol. 2012 Oct;52(2):111-22
pubmed: 22161226
J Comp Pathol. 1994 Feb;110(2):145-52
pubmed: 8040382